Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 280338생성일: 2026년 10월 23일
Potassium Iodide → N-[1-[2-(ethenyloxy)ethyl]-4-piperidinyl]-1-(4-fluorophenylmethyl)-1H-benzimidazol-2-amine
https://huagongshe.com/ko/reaction/280338
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Potassium Iodide | HCID 4875 | — |
| 반응물 | 2-Chloroethyl vinyl ether | HCID 8074 | — |
| 반응물 | Sodium Carbonate | HCID 10340 | — |
| 반응물 | Norastemizole hydrobromide | HCID 3018631 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | N-[1-[2-(ethenyloxy)ethyl]-4-piperidinyl]-1-(4-fluorophenylmethyl)-1H-benzimidazol-2-amine | HCID 13653865 | 32% |
반응 단계
A mixture of 1.6 parts of 1-chloro-2-(ethenyloxy)ethane, 7.3 parts of 1-(4-fluorophenylmethyl)-N-(4-piperidinyl)-1H-benzimidazol-2-amine dihydrobromide, 3.1 parts of sodium carbonate, 0.1 parts of potassium iodide and 135 parts of N,N-dimethylformamide was stirred and heated overnight at 70° C. The reaction mixture was poured onto water and the product was extracted with 4-methyl-2-pentanone. The extract was dried, filtered and evaporated. The residue was purified by column chromatography over silica gel using a mixture of trichloromethane and methanol, saturated with ammonia, (96:4 by volume) as eluent. The pure fractions were collected and the eluent was evaporated. The residue was crystallized from acetonitrile, yielding 1.9 parts (32%) of N-[1-[2-(ethenyloxy)ethyl]-4-piperidinyl]-1-(4-fluorophenylmethyl)-1H-benzimidazol-2-amine; mp. 138.5° C. (compound 1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04588722 |
|---|
| 출처 데이터셋 | uspto-grants-1986_05 |
|---|
| ORD ID | ord-eec8b0d9934e41c8810236d0bc8d8b24 |
|---|
| 출처 메모 | uspto-grants-1986_05 |
|---|